Union européenne - français - EMA (European Medicines Agency)

argenx - efgartigimod alfa - myasthenia gravis - immunosuppresseurs - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.

Canada - français - Health Canada

argenx bv - efgartigimod alfa - solution - 20mg - efgartigimod alfa 20mg